The Prevalence of Metabolic Disorders in Various Phenotypes of Polycystic Ovary Syndrome: A Community-Based Study in Southwest Iran

September 2014 in “ Reproductive Biology and Endocrinology ”

Fahimeh Ramezani Tehrani, Homeira Rashidi, Mahnaz Bahri Khomami, Maryam Tohidi, Fereidoun Azizi

polycystic ovary syndrome PCOS hyperandrogenism insulin resistance cholesterol low-density lipoprotein triglycerides glucose metabolic syndrome LDL

TLDR Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

In a 2014 study involving 646 reproductive-aged women in Southwest Iran, Ramezani Tehrani et al. found that different phenotypes of polycystic ovary syndrome (PCOS) exhibited varying levels of metabolic disturbances. Women with phenotype A (oligo/anovulation + hyperandrogenism + polycystic ovaries) and phenotype C (hyperandrogenism + polycystic ovaries) had higher insulin levels and insulin resistance. Phenotype A also had higher levels of cholesterol, low-density lipoprotein, triglycerides, and glucose, while metabolic syndrome was more prevalent in phenotype B (oligo/anovulation + hyperandrogenism). The study concluded that the severest phenotype of PCOS, which includes all three components, showed the highest level of metabolic disturbances, indicating a need for metabolic screening in these patients.

View this study on rbej.biomedcentral.com →

Discuss this study in the Community →

Research cited in this study

9 / 9 results

research Metabolic Aspects of Different Phenotypes of Polycystic Ovary Syndrome: Iranian PCOS Prevalence Study

31 citations, January 2014 in “Clinical Endocrinology”

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

research Changes in the PCOS Phenotype with Age

62 citations, April 2013 in “Steroids”

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

research The Prevalence of Polycystic Ovary Syndrome in a Community Sample of Iranian Population: Iranian PCOS Prevalence Study

215 citations, January 2011 in “Reproductive Biology and Endocrinology”

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

research Phenotype and Metabolic Profile of South Asian Women with Polycystic Ovary Syndrome: Results from a Specialist Endocrine Clinic

111 citations, November 2010 in “Human Reproduction”

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

research Metabolic Features of the Reproductive Phenotypes of Polycystic Ovary Syndrome

286 citations, January 2009 in “Human Reproduction Update”

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

research Prevalence of Polycystic Ovary Syndrome in Unselected Women from Southern China

121 citations, April 2008 in “European Journal of Obstetrics & Gynecology and Reproductive Biology”

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

research Definitions, Prevalence, and Symptoms of Polycystic Ovaries and Polycystic Ovary Syndrome

278 citations, August 2004 in “Best Practice & Research in Clinical Obstetrics & Gynaecology”

Polycystic ovaries are defined by having 12 or more small follicles in each ovary and are found in up to 33% of women, while Polycystic Ovary Syndrome (PCOS) is the most common hormone disorder in women of reproductive age, potentially increasing risk of obesity, diabetes, and heart diseases.

research Androgen Excess in Women: Experience with Over 1000 Consecutive Patients

947 citations, February 2004 in “The Journal of Clinical Endocrinology and Metabolism”

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

research Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome (PCOS)

4025 citations, December 2003 in “Human Reproduction”

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Similar Research

6 / 1000+ results

research Polycystic Ovarian Syndrome: Correlation Between Hyperandrogenism, Insulin Resistance, and Obesity

195 citations, November 2019 in “Clinica Chimica Acta”

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

research Selenium and Polycystic Ovary Syndrome: Current Knowledge and Future Directions

16 citations, May 2019 in “Hormone and Metabolic Research”

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.

research Polycystic Ovary Syndrome: Comprehensive Management in Primary Care

September 2002 in “Comprehensive Therapy”

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

research The Pediatric Origins of Polycystic Ovary Syndrome

January 2001 in “Cambridge University Press eBooks”

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.

research Ovarian Hypertension: Polycystic Ovary Syndrome

60 citations, May 2011 in “Endocrinology and Metabolism Clinics of North America”

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

research Evidence-Based Approach to Cutaneous Hyperandrogenism in Women

42 citations, July 2015 in “Journal of The American Academy of Dermatology”

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.